JPWO2021153635A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021153635A5
JPWO2021153635A5 JP2021574083A JP2021574083A JPWO2021153635A5 JP WO2021153635 A5 JPWO2021153635 A5 JP WO2021153635A5 JP 2021574083 A JP2021574083 A JP 2021574083A JP 2021574083 A JP2021574083 A JP 2021574083A JP WO2021153635 A5 JPWO2021153635 A5 JP WO2021153635A5
Authority
JP
Japan
Prior art keywords
mono
enoyl
sorbitan
tetramethyloctadec
propylene glycol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021574083A
Other languages
English (en)
Japanese (ja)
Other versions
JP7761929B2 (ja
JPWO2021153635A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/002917 external-priority patent/WO2021153635A1/ja
Publication of JPWO2021153635A1 publication Critical patent/JPWO2021153635A1/ja
Publication of JPWO2021153635A5 publication Critical patent/JPWO2021153635A5/ja
Priority to JP2025171135A priority Critical patent/JP2026001219A/ja
Application granted granted Critical
Publication of JP7761929B2 publication Critical patent/JP7761929B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021574083A 2020-01-27 2021-01-27 安全性の高い非ラメラ液晶形成性組成物 Active JP7761929B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025171135A JP2026001219A (ja) 2020-01-27 2025-10-09 安全性の高い非ラメラ液晶形成性組成物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2020011237 2020-01-27
JP2020011237 2020-01-27
JP2020211758 2020-12-21
JP2020211758 2020-12-21
PCT/JP2021/002917 WO2021153635A1 (ja) 2020-01-27 2021-01-27 安全性の高い非ラメラ液晶形成性組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025171135A Division JP2026001219A (ja) 2020-01-27 2025-10-09 安全性の高い非ラメラ液晶形成性組成物

Publications (3)

Publication Number Publication Date
JPWO2021153635A1 JPWO2021153635A1 (https=) 2021-08-05
JPWO2021153635A5 true JPWO2021153635A5 (https=) 2024-02-02
JP7761929B2 JP7761929B2 (ja) 2025-10-29

Family

ID=77079915

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021574083A Active JP7761929B2 (ja) 2020-01-27 2021-01-27 安全性の高い非ラメラ液晶形成性組成物
JP2025171135A Pending JP2026001219A (ja) 2020-01-27 2025-10-09 安全性の高い非ラメラ液晶形成性組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025171135A Pending JP2026001219A (ja) 2020-01-27 2025-10-09 安全性の高い非ラメラ液晶形成性組成物

Country Status (5)

Country Link
US (1) US20230105725A1 (https=)
EP (1) EP4098281A4 (https=)
JP (2) JP7761929B2 (https=)
CN (1) CN115461084B (https=)
WO (1) WO2021153635A1 (https=)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5312814A (en) * 1992-12-09 1994-05-17 Bristol-Myers Squibb Co. α-phosphonocarboxylate squalene synthetase inhibitors
JP3808412B2 (ja) * 2002-07-26 2006-08-09 花王株式会社 養毛料
US7846903B2 (en) 2004-10-19 2010-12-07 National Institute Of Advanced Industrial Science And Technology Type II cubic liquid crystal composition
KR101245022B1 (ko) * 2005-01-21 2013-03-19 카무러스 에이비 약제학적 지질 조성물
RU2532165C2 (ru) * 2008-09-22 2014-10-27 Дзе Проктер Энд Гэмбл Компани Определенные разветвленные альдегиды, спирты, поверхностно -активные вещества и потребительские продукты на их основе
JP5207420B2 (ja) 2009-12-25 2013-06-12 株式会社ケムジェネシス 低粘度液晶化合物
JP2012017318A (ja) * 2010-06-07 2012-01-26 Nikko Chemical Co Ltd 液晶及びそれを含有する皮膚外用剤
MX350929B (es) * 2011-12-05 2017-09-26 Camurus Ab Formulaciones peptidicas robustas de liberación controlada.
WO2014101051A1 (en) * 2012-12-27 2014-07-03 Kimberly-Clark Worldwide, Inc. Water soluble farnesol analogs and their use
KR101586789B1 (ko) 2012-12-28 2016-01-19 주식회사 종근당 양이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586791B1 (ko) 2012-12-28 2016-01-19 주식회사 종근당 ＧｎＲＨ 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101601035B1 (ko) * 2013-02-28 2016-03-08 주식회사 종근당 키토산 및 액상결정 형성 물질을 포함하는 유전자 전달용 조성물
WO2014178256A1 (ja) * 2013-05-01 2014-11-06 株式会社ファルネックス 癒着防止剤
US10814351B2 (en) 2013-08-12 2020-10-27 The Boeing Company High-viscosity sealant application system
JP2019193684A (ja) * 2016-09-05 2019-11-07 株式会社ファルネックス 油分を含むエマルションを用いた癒着防止剤
JP2019099478A (ja) * 2017-11-30 2019-06-24 株式会社ファルネックス 非ラメラ液晶再構成能を有する粉末微粒子製剤
AU2019258590B2 (en) * 2018-04-26 2022-09-08 NanoMed Holdings Pty Ltd Gemcitabine amphiphile prodrugs

Similar Documents

Publication Publication Date Title
ES2314408T3 (es) Formulaciones de hfc en solucion que contienen un anticolinergico.
ES2289832T3 (es) Composicion farmaceutica de aerosol que contiene hfa 227 y hfa 134a.
ES2211108T3 (es) Formulaciones farmaceuticas para aerosoles con dos o mas sustancias activas.
JP6023181B2 (ja) 爪に投与するための医薬組成物
CN1138532C (zh) 药用气溶胶组合物
EP0776202B1 (de) Liposomal verkapseltes taxol, seine herstellung und seine verwendung
ES2241872T3 (es) Sales del promedicamento combretastatina a-4 con compuestos que contienen nitrogeno.
US10376479B2 (en) Endoxifen compositions and methods
JP5992324B2 (ja) 脂肪酸モノグリセリド組成物
CN110433089B (zh) 用于促进皮肤吸收的囊泡以及其制备方法
JP2002532536A5 (https=)
CN107427482A (zh) 凝血酸的多囊脂质体制剂
JP2013500239A5 (https=)
WO2004016244A2 (en) Pharmaceutical compositions for buccal delivery of pain relief medications
WO2007123867A2 (en) Stable solutions of prostaglandin and uses of same
EP0602181A1 (en) Medicinal aerosol formulations
JP2006501220A (ja) 薬剤の投与及び吸収促進方法
JPWO2021153635A5 (https=)
RS52131B (sr) Nove kompozicije na bazi taksoida
BRPI0619565A2 (pt) composições lipossÈmicas
JP2023518084A (ja) 高透過性薬物を含む医薬組成物の安定性を改善する方法、及びそれにより得られる医薬組成物
WO2005067517A2 (en) Encapsulation of chemical compounds in fluorous-core and fluorous-inner-shell micelles formed from semifluorinated-block or fluorinated-block copolymers
JPWO2023008498A5 (https=)
JP2016128455A (ja) ピラゾロン誘導体製剤
JP3990728B2 (ja) Ｎ−［４−オキソ−２−（１ｈ−テトラゾール−５−イル）−４ｈ−１−ベンゾピラン−８−イル］−４−（４−フェニルブトキシ）ベンズアミドの塩